Envoy Operating Cycle from 2010 to 2026

COCH Stock   0.60  0.08  15.37%   
Envoy Medical's Operating Cycle is increasing with slightly volatile movements from year to year. Operating Cycle is estimated to finish at 2,048 this year. For the period between 2010 and 2026, Envoy Medical, Operating Cycle quarterly trend regression had mean deviation of  424.00 and range of 1.6 K. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
K
Current Value
K
Quarterly Volatility
564.56366866
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Envoy Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Envoy Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.3 K, Other Operating Expenses of 11.9 M or Total Operating Expenses of 11.3 M, as well as many indicators such as Price To Sales Ratio of 258, Dividend Yield of 0.0729 or Days Sales Outstanding of 1.3 K. Envoy financial statements analysis is a perfect complement when working with Envoy Medical Valuation or Volatility modules.
  
Build AI portfolio with Envoy Stock
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
The Operating Cycle trend for Envoy Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Envoy Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Envoy Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Envoy Medical over the last few years. It is Envoy Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Envoy Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Envoy Operating Cycle Regression Statistics

Arithmetic Mean893.47
Geometric Mean783.87
Coefficient Of Variation63.19
Mean Deviation424.00
Median606.73
Standard Deviation564.56
Sample Variance318,732
Range1.6K
R-Value0.71
Mean Square Error166,978
R-Squared0.51
Significance0
Slope79.75
Total Sum of Squares5.1M

Envoy Operating Cycle History

2026 2047.97
2025 1950.45
2024 2167.17
2023 730.36
2022 1012.29

About Envoy Medical Financial Statements

Investors use fundamental indicators, such as Envoy Medical's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Envoy Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating CycleKK

Currently Active Assets on Macroaxis

When determining whether Envoy Medical is a strong investment it is important to analyze Envoy Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Envoy Medical's future performance. For an informed investment choice regarding Envoy Stock, refer to the following important reports:
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is there potential for Health Care Equipment & Supplies market expansion? Will Envoy introduce new products? Factors like these will boost the valuation of Envoy Medical. Projected growth potential of Envoy fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Envoy Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.37)
Revenue Per Share
0.01
Quarterly Revenue Growth
(0.25)
Return On Assets
(1.45)
Understanding Envoy Medical requires distinguishing between market price and book value, where the latter reflects Envoy's accounting equity. The concept of intrinsic value - what Envoy Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Envoy Medical's price substantially above or below its fundamental value.
It's important to distinguish between Envoy Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Envoy Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Envoy Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.